| Pharmaceutical active ingredients: |
| Meclofenoxate |
| Available forms, composition and doses of Atsephen: |
| N / A |
| Atsephen medical category: |
| Human:Alzheimer's disease treatment drugsSenile dementia symptoms treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06BX01 - Meclofenoxate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Movens | Meclofenamate Sodium; Meclofenamic Acid | Pharmafair |
| Acephene | Meclofenoxate | Unidentified Pharmaceutical Company |
| Amipolen | Meclofenoxate | Unidentified Pharmaceutical Company |
| AT Sefen | Meclofenoxate | Unidentified Pharmaceutical Company |
| Atsefen | Meclofenoxate | Unidentified Pharmaceutical Company |
| Brenal | Meclofenoxate | Unidentified Pharmaceutical Company |
| Centrexin | Meclofenoxate | Unidentified Pharmaceutical Company |
| Cerebon | Meclofenoxate | Unidentified Pharmaceutical Company |
| Cetrexin | Meclofenoxate | Unidentified Pharmaceutical Company |
| Clocete | Meclofenoxate | Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Atroscine | Scopolamine Hydrobromide | Unidentified Pharmaceutical Company |
| Atrosulf | Atropine | Unidentified Pharmaceutical Company |
| Atrovis | Clofibrate | Unidentified Pharmaceutical Company |
| Atsefen | Meclofenoxate | Unidentified Pharmaceutical Company |
| Atsemin | Aminocaproic Acid | Unidentified Pharmaceutical Company |
| Attaclay | Attapulgite | Unidentified Pharmaceutical Company |
| Attacote | Attapulgite | Unidentified Pharmaceutical Company |
| Attagel | Attapulgite | Unidentified Pharmaceutical Company |
| Attapulgus Clay | Attapulgite | Unidentified Pharmaceutical Company |
| Attasorb | Attapulgite | Unidentified Pharmaceutical Company |